Medical-business accelerator receives
WINNIPEG – Manitoba’s growing life sciences cluster
may soon be able to get its ideas to market faster with a $1.19 million
investment from Western Economic Diversification Canada (WD). Biomedical
Commercialization Canada, a life sciences business accelerator, will use
the funds to provide innovators and entrepreneurs with the business
tools they need to become successful.
Steven Fletcher, Member of Parliament for
Charleswood-St.James-Assiniboia, made the announcement on behalf of the
Honourable Carol Skelton, Minister of National Revenue and Minister of
Western Economic Diversification.
According to a 2004 KPMG study of medical devices production in 11
countries, Canada ranks first worldwide, with a 5.6% cost advantage over
the United States. Building on this opportunity, Biomedical
Commercialization Canada Inc. (BCC) was launched in 2005 in Winnipeg, in
the Commercialization Centre for Biomedical Technologies.
This business incubator for biomedical technologies works with
entrepreneurs and start-up companies to help commercialize research and
technology and connect know-how into useful products.
Recognizing the need for global relationships, BCC has developed a
working relationship with the Canterbury Enterprise Hub at the
University of Kent to promote collaboration between Canadian and UK
biomedical technology and markets.
“Manitoba’s life sciences cluster presents economic opportunities for
the province and promises medical innovation for all Canadians,” said
Fletcher. “Canada’s new government made a commitment to creating an
environment that supports jobs and growth, and we are honouring that
commitment to Canadians.
Innovators and entrepreneurs looking to move new technologies from the
laboratory to the marketplace need specialized assets and infrastructure
in areas such as business operations, management, data security and
quality control. Biomedical Commercialization Canada (BCC) will provide
these business applications in a secure and accessible environment that
will also allow clients to collaborate with partner companies in
Manitoba and around the world.
“By creating a shared business environment, we can reduce cost and
provide clients with the programs they will need to be successful,” said
Joe Wery, BCC President and CEO. “We will not only provide the business
tools, but we will also show them how to use these tools to establish
best business practices that will increase their investment
The life sciences sector in Manitoba consists of companies and research
institutions that have expertise in cardiovascular and respiratory
diseases, infections diseases, diagnostics, medical devices, and
pharmaceuticals. Examples include the National Research Council
Institute for Bio-diagnostics, the Canada Science Centre for Human and
Animal Health, the St. Boniface General Hospital Research Centre and the
University of Manitoba.
Biomedical Commercialization Canada Inc. is a not-for-profit
organization founded by the National Research Council of Canada and the
Province of Manitoba. Led by a private sector board of directors, BCC
designs, implements and manages a suite of technology commercialization
services and programs for Canadian biomedical technology and related
Western Economic Diversification Canada (WD) is a department of the
Government of Canada that works in partnership with the provinces,
industry associations and communities to stimulate and encourage
diversification of the western economy, as well as to represent the
interests of the West in national decision-making.
For more information, please visit
www.biomedcanada.com, or email Marshall Ring, Senior Program
Development Officer, BCC, at firstname.lastname@example.org.